The course of seizures in patient with supratentorial brain meningiomas (cohort retrospective study)

Authors

DOI:

https://doi.org/10.15587/2519-4798.2019.174509

Keywords:

Meningioma, epilepsy, neuro-onсology, brain membranes, neurosurgery

Abstract

Meningioma is the most common brain tumour with a favourable prognosis for a long life. Often epileptic seizures are the main clinical manifestation of meningiomas. However, surgical treatment does not always deprive patients of attacks, and vice versa, some attacks after surgery arise for the first time. Investigating the factors that influence the course of epileptic seizures will optimize treatment tactics

Aim: Identify the factors that affect the preservation or emergence of epileptic seizures in patients operated for supratentorial meningiomas of the brain with a view to further personalized correction of anticonvulsants therapies.

Materials and methods: A retrospective analysis of the course of the disease was performed in 242 patients with totally removed supratentorial meningioma of the brain. The remote results of the disease in 176 people were evaluated. The average duration of observation was 37.0 months (12-111).

Results: In 55 (75.3±5.0%) out of 73 patients who had a seizures before surgical treatment, they disappeared in the distant period. Of the 103 patients without trial before surgery, they subsequently arose in 9 people (8,7±2,8%). Seizures were preserved in 8 (32.0±9.5%) out of 25 men and 10 (20.8±5.9%) out of 48 women.

In 6 (50.0±15.1%) of 12 patients with localization of meningiomas in the left parietal lobe epileptic seizures were preserved, this localization was significantly more frequent in the group of patients with persistent seizures after surgery, p <0.05.

The average duration of the disease before surgery is significantly higher in patients who did not seizure free after intervention - 41.3 and 14.3 months respectively. Among those who had a history of seizures less than year, 40 (90.9±4.3%) of 44 patients were seizure free, and in those who were ill more than a year in 13 (56.5±10.6%) out of 23 cases. Among patients who had more than 10 attacks before intervention, after surgery they returned in 60.0±13.1% of cases, whereas among patients with less than 10 seizures before surgery, recidivism was only in 15.5±4.3% of patients. In the group of patients with persistent seizures after surgery, patients with more than 10 seizures in history were significantly more likely to suffer, p<0.01.

Conclusions: Total removal of meningiomas can make about ¾ patients seizure free. Localization of the tumour in the left parietal region is associated with a greater likelihood of preservation of epilepsy after surgery. The longer patient has the illness and the more seizures he has, the greater the probability of convulsions after surgical treatment

Author Biographies

Taras Studeniak, State Higher Educational Establishment «Uzhhorod National University» Narodna sq., 3, Uzhgorod, Ukraine, 88000

AssistantDepartment of Neurology, Neurosurgery and Psychiatry

Volodymyr Smolanka, State Higher Educational Establishment «Uzhhorod National University» Narodna sq., 3, Uzhgorod, Ukraine, 88000

MD, Professor

Department of Neurology, Neurosurgery and Psychiatry

Andriy Smolanka, State Higher Educational Establishment «Uzhhorod National University» Narodna sq., 3, Uzhgorod, Ukraine, 88000

PhD, Assistant

Department of Neurology, Neurosurgery and Psychiatry

References

  1. Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J. et. al. (2014). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro-Oncology, 16 (4), 1–63. doi: http://doi.org/10.1093/neuonc/nou223
  2. Studeniak, T. O. (2017). Riznomanitnist nevrolohichnoi symptomatyky u patsiientiv iz supratentorialnymy meninhiomamy holovnoho mozku [Neurological symptoms diversity in patients with brain supratentorial meningiomas]. Scientific herald of UzhNU. Series: Medicine, 1 (55), 117–119.
  3. Chen, D. Y., Chen, C. C., Crawford, J. R., Wang, S. G. (2018). Tumor-related epilepsy: epidemiology, pathogenesis and management. Journal of Neuro-Oncology, 139 (1), 13–21. doi: http://doi.org/10.1007/s11060-018-2862-0
  4. Polishchuk, M. Ye., Mekhrzi, M. K., Sirko, A. H. et. al. (2018). Neiroradiolohichna diahnostyka meninhitom sered pervynnykh pukhlyn bichnykh shlunochkiv [Neuro-radiological diagnosis of meningiomas among the primary tumors of the lateral ventricles]. Endovascular neurorthosurgery, 1 (23), 14–23.
  5. Rogers, L., Barani, I., Chamberlain, M., Kaley, T. J., McDermott, M., Raizer, J. et. al. (2015). Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. Journal of Neurosurgery, 122 (1), 4–23. doi: http://doi.org/10.3171/2014.7.jns131644
  6. Tanti, M. J., Marson, A. G., Jenkinson, M. D. (2017). Epilepsy and adverse quality of life in surgically resected meningioma. Acta Neurologica Scandinavica, 136 (3), 246–253. doi: http://doi.org/10.1111/ane.12711
  7. Englot, D. J., Magill, S. T., Han, S. J., Chang, E. F., Berger, M. S., McDermott, M. W. (2016). Seizures in supratentorial meningioma: a systematic review and meta-analysis. Journal of Neurosurgery, 124 (6), 1552–1561. doi: http://doi.org/10.3171/2015.4.jns142742
  8. Studeniak, T. O. (2017). Prohnostychni kryterii rozvytku symptomatychnoi epilepsii u patsiientiv z supratentorialnymy meninhiomamy holovnoho mozku [Prognostic criteria for the development of symptomatic epilepsy in patients with supratentorial meningiomas of the brain]. Epileptology Bulletin, 1 (47-48), 33–38.
  9. Englot, D. J., Berger, M. S., Barbaro, N. M., Chang, E. F. (2011). Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia, 53 (1), 51–57. doi: http://doi.org/10.1111/j.1528-1167.2011.03269.x
  10. Chan, R. C., Thompson, G. B. (1984). Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. Journal of Neurosurgery, 60 (1), 52–60. doi: http://doi.org/10.3171/jns.1984.60.1.0052
  11. Studeniak, T. O., Smolanka, V. I., Smolanka, A. V. (2018). Long-term results of meningiomas surgical treatment. Analysis of 110 cases. ScienceRise: Medical Science, 4 (24), 32–37. doi: http://doi.org/10.15587/2519-4798.2018.132680
  12. Seyedi, J. F., Pedersen, C. B., Poulsen, F. R. (2018). Risk of seizures before and after neurosurgical treatment of intracranial meningiomas. Clinical Neurology and Neurosurgery, 165, 60–66. doi: http://doi.org/10.1016/j.clineuro.2018.01.002
  13. Ali, A., Bagchi, A., Mills, S., Giraldi, D., Chavredakis, E., Brodbelt, A., Jenkinson, M. (2018). Risk factors for developing post-operative seizures following meningioma resection. Neuro-Oncology, 20 (1), 1. doi: http://doi.org/10.1093/neuonc/nox237.001
  14. Xue, H., Sveinsson, O., Bartek, J., Förander, P., Skyrman, S., Kihlström, L. et. al. (2018). Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study. Acta Neurochirurgica, 160 (3), 589–596. doi: http://doi.org/10.1007/s00701-017-3434-3
  15. Hwang, K., Joo, J.-D., Kim, Y.-H., Han, J. H., Oh, C. W., Yun, C.-H. et. al. (2019). Risk factors for preoperative and late postoperative seizures in primary supratentorial meningiomas. Clinical Neurology and Neurosurgery, 180, 34–39. doi: http://doi.org/10.1016/j.clineuro.2019.03.007

Published

2019-08-02

How to Cite

Studeniak, T., Smolanka, V., & Smolanka, A. (2019). The course of seizures in patient with supratentorial brain meningiomas (cohort retrospective study). ScienceRise: Medical Science, (4 (31), 24–29. https://doi.org/10.15587/2519-4798.2019.174509

Issue

Section

Medical Science